Keiji Hirota

机构：Kyoto University, Meiji Pharmaceutical University · ORCID：0000-0002-4737-0661

发表论文 72 篇 · 总被引 13000 次 · h-index 38

代表论文

• The pathogenicity of Th17 cells in autoimmune diseases (2019 · Seminars in Immunopathology · 被引 585)
• Conversion of antigen-specific effector/memory T cells into Foxp3-expressing T reg cells by inhibition of CDK8/19 (2019 · Science Immunology · 被引 141)
• Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis (2020 · Immunological Reviews · 被引 93)
• Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells (2021 · Immunity · 被引 92)
• Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity (2020 · Frontiers in Immunology · 被引 61)
• Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation (2019 · Nature Communications · 被引 55)